PTC Therapeutics Inc. Stock
PTC Therapeutics Inc. Stock
PTC Therapeutics Inc. dominated the market today, gaining €3.20 (12.030%).
Currently there is a rather positive sentiment for PTC Therapeutics Inc. with 14 Buy predictions and 5 Sell predictions.
With a target price of 41 € there is a positive potential of 37.58% for PTC Therapeutics Inc. compared to the current price of 29.8 €.
Our community identified positive and negative aspects for PTC Therapeutics Inc. stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the PTC Therapeutics Inc. stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of PTC Therapeutics Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Cons
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of PTC Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| PTC Therapeutics Inc. | 12.030% | 27.350% | 12.030% | -36.325% | 18.254% | -12.353% | -9.670% |
| Ironwood Pharmaceuticals | 0.690% | -2.685% | -8.228% | -22.872% | -28.922% | -21.622% | - |
| Sage Therapeutics Inc. | -3.520% | 7.851% | -25.000% | -69.792% | -34.750% | -79.867% | - |
| Novocure Ltd | 8.240% | 1.864% | -20.671% | -80.817% | -19.615% | -93.244% | - |
Comments
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $45.00 price target on the stock.
Show more
Ratings data for PTCT provided by MarketBeat
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at Jefferies Financial Group Inc. from $33.00 to $35.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PTCT provided by MarketBeat
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $45.00 price target on the stock.
Show more
Ratings data for PTCT provided by MarketBeat